15 Ingenious Ways You Can Do With the Rivastigmine Market.
Rivastigmine Market is an inhibitor of the cholinesterase enzymes butyrylcholinesterase and acetylcholinesterase. It's a cholinergic agent that helps with Alzheimer's and Parkinson's disease treatment. Because of its tiny molecular size, the medicine can be taken orally or applied as transdermal patches. The growing elderly population is a primary driver of Rivastigmine Market expansion. According to the Alzheimer's Association, the chance of developing dementia doubles every five years beyond the age of 65. Furthermore, as the global incidence of cardiovascular disorders rises, so does the occurrence of Alzheimer's disease, driving up demand for rivastigmine. According to the National Center for Biotechnology Information, the global incidence of cardiovascular illnesses was roughly 22.5 per 1,000 people in 2013, implying a dementia risk. Dementia can also be exacerbated by diseases like diabetes and high blood pressure. Geographically, the Rivastigmine Market is...